Ginkgo Bioworks Holdings, Inc.
DNA · NYSE
Bulios Fair Price
$5.8
45.6% downside
Trenutna cena
$10.66
Po podatkih Bulios Fair Price je delnica DNA trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Ginkgo Bioworks Holdings, Inc. (DNA) is a biotechnology company focused on synthetic biology and engineering microorganisms. The company uses advanced technologies and biological systems to create new organisms and biological functions for various applications. Ginkgo Bioworks specializes in genetic modification and design of microorganisms, enabling the production of novel drugs, biochemical substances, industrial products, and other biologically-based technologies. The company collaborates with various industries and pharmaceutical companies on the development of new products and innovations that can have a positive impact on the environment and human health. Ginkgo Bioworks Holdings, Inc. (DNA) shares may be an attractive investment opportunity for investors interested in the biotechnology sector and seeking an investment in a company focused on innovation and the development of biological technologies with the potential for broader societal impact.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Jason Kelly
Employees
485
Headquarters
Boston
Prihajajoči dogodki
Earnings
Upcoming earnings report